Israel - English - Ministry of Health

unipharm ltd, israel - roxithromycin - tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - roxithromycin -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

hexal -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: purified talc; colloidal anhydrous silica; hypromellose; titanium dioxide; magnesium stearate; povidone; hyprolose; glucose; maize starch; propylene glycol; poloxamer - for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms in; acute pharyngitis, tonsillitis, and sinusitis. acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia (including atypical pneumonia). skin and soft tissue infections and non-gonococcal urethritis

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - roxithromycin -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - roxithromycin -